From the latest healthcare headlines to MedAxiom community news, this is the place to learn more and stay informed. Updated regularly.
Blog | Published: Thursday, April 28, 2016
Proper documentation and coding is key to an organization not missing out on missed premiums or incentives under the Medicare Advantage plan. Larry Sobal follows-up on last week’s blog post about this important issue—and how ignorance or mastery of Medicare Advantage can greatly impact organizations.
Blog | Published: Wednesday, April 27, 2016
It’s hard to determine the future path of an organization without a plan. That includes a formal process that takes into account an ever-changing workforce. In Part 2 of his three-part blog series on workforce planning, Joel Sauer examines qualitative measures in health care that can forecast workforce needs.
News | Published: Monday, April 25, 2016
Last week CMS released the Fiscal Year 2017 (FY17) Proposed Inpatient Rule, which outlines the proposed requirements and payment changes that will go into effect October 1, 2016. Cardiovascular related services continue to play a significant role in terms of inpatient volumes, with Heart Failure continuing to lead the way. Ryan Graver highlights and summarizes the key points of the proposed rule in this blog.
Blog | Published: Tuesday, April 19, 2016
Partner News | Published: Tuesday, April 12, 2016Ideal Protein today announced the appointment of leading cardiology experts to its newly-formed cardiology advisory board. Members include: Tran Tien Chanh, M.D., Ph.D.; Douglas W. Rothrock, M.D.; David
Blog | Published: Thursday, April 7, 2016
Forget about consumer ratings for cars and restaurants. Doctors have also joined the list, and, well, there’s a website for that. Actually, there’s a myriad of websites. These days, everything under the sun is rated and ranked. I’m exploring a recent listing of the best and worst states for doctors to practice medicine.
Partner News | Published: Monday, April 4, 2016April 3, 2016—Two-year data from the EVOLVE II trial supporting outcomes, including safety, with Boston Scientific’s Synergy bioabsorbable polymer drug-eluting stent (DES) system were presented at
Partner News | Published: Thursday, March 31, 2016
Boston Scientific won FDA approval for its Blazer Open-Irrigated RF ablation catheter used in treating Type 1 atrial flutter. The decision was based on results of the BLOCk-CTI prospective, randomized clinical trial that involved 302 patients at 24 hospitals around the country.